Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis
- PMID: 20685997
- PMCID: PMC3078518
- DOI: 10.1523/JNEUROSCI.0146-10.2010
Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis
Abstract
An expanded polyglutamine (polyQ) stretch in the protein huntingtin (htt) induces self-aggregation into inclusion bodies (IBs) and causes Huntington's disease (HD). Defining precise relationships between early observable variables and neuronal death at the molecular and cellular levels should improve our understanding of HD pathogenesis. Here, we used an automated microscope that tracks thousands of neurons individually over their entire lifetime to quantify interconnected relationships between early variables, such as htt levels, polyQ length, and IB formation, and neuronal death in a primary striatal model of HD. The resulting model revealed that mutant htt increases the risk of death by tonically interfering with homeostatic coping mechanisms rather than producing accumulated damage to the neuron, htt toxicity is saturable, the rate-limiting steps for inclusion body formation and death can be traced to different conformational changes in monomeric htt, and IB formation reduces the impact of the starting levels of htt of a neuron on its risk of death. Finally, the model that emerges from our quantitative measurements places critical limits on the potential mechanisms by which mutant htt might induce neurodegeneration, which should help direct future research.
Figures




Similar articles
-
Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.J Gene Med. 2012 Jul;14(7):468-81. doi: 10.1002/jgm.2641. J Gene Med. 2012. PMID: 22700462
-
Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.Neurobiol Dis. 2005 Dec;20(3):785-98. doi: 10.1016/j.nbd.2005.05.017. Epub 2005 Jul 11. Neurobiol Dis. 2005. PMID: 16006135
-
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16. Neurobiol Dis. 2008. PMID: 18502655 Free PMC article.
-
Selective degeneration in YAC mouse models of Huntington disease.Brain Res Bull. 2007 Apr 30;72(2-3):124-31. doi: 10.1016/j.brainresbull.2006.10.018. Epub 2006 Nov 16. Brain Res Bull. 2007. PMID: 17352936 Review.
-
Huntington's Disease.Cold Spring Harb Perspect Biol. 2011 Jun 1;3(6):a007476. doi: 10.1101/cshperspect.a007476. Cold Spring Harb Perspect Biol. 2011. PMID: 21441583 Free PMC article. Review.
Cited by
-
Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.PLoS One. 2012;7(7):e41450. doi: 10.1371/journal.pone.0041450. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22848498 Free PMC article.
-
Cell-based screening: extracting meaning from complex data.Neuron. 2015 Apr 8;86(1):160-74. doi: 10.1016/j.neuron.2015.02.023. Neuron. 2015. PMID: 25856492 Free PMC article. Review.
-
Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy.PLoS One. 2013 Jun 10;8(6):e64953. doi: 10.1371/journal.pone.0064953. Print 2013. PLoS One. 2013. PMID: 23762270 Free PMC article.
-
Role of SUMOylation in Neurodegenerative Diseases.Cells. 2022 Oct 27;11(21):3395. doi: 10.3390/cells11213395. Cells. 2022. PMID: 36359791 Free PMC article. Review.
-
Mitochondrial integrity in neurodegeneration.CNS Neurosci Ther. 2019 Jul;25(7):825-836. doi: 10.1111/cns.13105. Epub 2019 Feb 11. CNS Neurosci Ther. 2019. PMID: 30746905 Free PMC article. Review.
References
-
- Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805–810. - PubMed
-
- Benn CL, Landles C, Li H, Strand AD, Woodman B, Sathasivam K, Li SH, Ghazi-Noori S, Hockly E, Faruque SM, Cha JH, Sharpe PT, Olson JM, Li XJ, Bates GP. Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. Hum Mol Genet. 2005;14:3065–3078. - PubMed
-
- Bennett EJ, Bence NF, Jayakumar R, Kopito RR. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell. 2005;17:351–365. - PubMed
-
- Brooks E, Arrasate M, Cheung K, Finkbeiner SM. Using antibodies to analyze polyglutamine stretches. Methods Mol Biol. 2004;277:103–128. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AG11385/AG/NIA NIH HHS/United States
- R01 AG011385/AG/NIA NIH HHS/United States
- 2R01 NS045091/NS/NINDS NIH HHS/United States
- R01 NS039074/NS/NINDS NIH HHS/United States
- 2R01 NS039074/NS/NINDS NIH HHS/United States
- 2P01 AG022074/AG/NIA NIH HHS/United States
- R01 AG018440/AG/NIA NIH HHS/United States
- R01 NS045191/NS/NINDS NIH HHS/United States
- R37 AG018440/AG/NIA NIH HHS/United States
- AG022074/AG/NIA NIH HHS/United States
- R01 NS045091/NS/NINDS NIH HHS/United States
- AG18440/AG/NIA NIH HHS/United States
- P01 AG022074/AG/NIA NIH HHS/United States
- R37 AG011385/AG/NIA NIH HHS/United States
- C06 RR018928/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical